Onconetix, Inc. Other Receivables, Net, Current
Onconetix, Inc. (ONCO) had Other Receivables, Net, Current of $50.00 thousand as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Nontrade Receivables › Other Receivables, Net, Current
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-13
- 2025-12-31: Other Receivables, Net, Current $50.00K.
- 2024-12-31: Other Receivables, Net, Current $250.31K.
- 2024-09-30: Other Receivables, Net, Current $0.00.
- 2024-06-30: Other Receivables, Net, Current $0.00.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2025-12-31 | $50.00K 10-Q · filed 2026-08-13 |
| 2024-12-31 | $250.31K 10-Q · filed 2025-11-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-12-10 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-29 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-20 |
| 2023-12-31 | $0.00 10-Q · filed 2024-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |